TORIDOLL (3397) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
12 Apr, 2026Executive summary
Q1 FY3/25 consolidated revenue reached a record ¥65.9 billion, with business profit at a record ¥4.4 billion, driven by Marugame Seimen's strong performance.
Marugame Seimen segment achieved record business profit of ¥5.7 billion and a margin of 17.9%.
Operating profit declined 10.2% year-over-year to ¥3,518 million due to impairment losses and one-off expenses, mainly in the Overseas segment.
Profit attributable to owners of the parent dropped 42.8% year-over-year to ¥1,513 million, impacted by higher income tax expense and one-time overseas costs.
Progress is generally in line with the consolidated performance forecast.
Financial highlights
Revenue increased 25.1% year-over-year to ¥65,856 million.
Business profit rose 13.3% year-over-year to ¥4,423 million.
EBITDA for Q1 FY3/25 was ¥11,755 million, up 12.2% year-over-year; adjusted EBITDA was ¥12,333 million, up 14.5%.
Operating profit decreased 10.2% year-over-year to ¥3,518 million due to impairment losses and one-off expenses.
Basic EPS for Q1 FY3/25 was ¥16.24, down from ¥29.30 year-over-year.
Outlook and guidance
Full-year revenue forecast is ¥265 billion, up 14.2% from the previous year.
Full-year business profit forecast is ¥18.1 billion, up 24.5% year-over-year.
Operating profit for the year is projected at ¥14.1 billion, up 21.1% year-over-year.
Full-year profit attributable to owners of the parent is projected at ¥6,460 million, up 13.8% year-over-year.
Overseas segment profitability expected to recover as restructuring and cost controls are implemented.
Latest events from TORIDOLL
- Record interim revenue and profit, but overseas weakness and one-time costs lowered profit outlook.3397
Q2 202512 Apr 2026 - Record revenue and profit growth achieved, but owner profit declined amid higher costs and tax impacts.3397
Q3 202512 Apr 2026 - Record revenue and profit, but net profit fell on overseas impairments; strong rebound forecast.3397
Q4 202512 Apr 2026 - Record Q1 revenue and profit with robust domestic growth and improved overseas profitability.3397
Q1 202612 Apr 2026 - Record interim profit and revenue, with robust domestic growth and overseas profit gains.3397
Q2 202612 Apr 2026 - Record revenue and profit growth, led by domestic strength and overseas profit gains.3397
Q3 202612 Apr 2026